Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-11-15

Clinical Trial Update: High-Dose Vitamin D Deficiency in Burn Injury [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating high-dose vitamin D for burn injury has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D (Cholecalciferol) (Cholecalciferol)

Snippet

Sponsor: The University of Texas Medical Branch, Galveston | Conditions: Burn | Phase 3 | Status: WITHDRAWN